Prognostic Stage IIA Breast Cancer AJCC v8 Recruiting Phase 3 Trials for Tucatinib (DB11652)

Also known as: Prognostic Stage 2A Breast Cancer AJCC v8

DBCOND0109633 (Prognostic Stage IIA Breast Cancer AJCC v8)Recruiting3 IdentifierTitlePurposeDrugs
NCT04457596T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer, the CompassHER2 RD TrialTreatment